Aslan Fred Insider Trades & Stock Holdings

Chief Executive Officer · Artiva Biotherapeutics, Inc. · Latest filing Oct 6, 2026

Aslan Fred, Chief Executive Officer at Artiva Biotherapeutics, Inc. has 2 Form 4 trades on file since Oct 5, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($590.71K), net -$590.71K. Latest filing: disposed of 23.46K shares of $ARTV on Oct 6, 2026 at $7.20.

Trades on file

2

Open-market bought

$0

Open-market sold

$590.71K

Net open-market

-$590.71K

Latest filing

Oct 6, 2026

All insider trades by Aslan Fred

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 6, 2026	$ARTV	Sell (Open-market sale) 10b5-1	23.46K	$7.20	$168.88K			-13.5%			Chief Executive Officer		—
Oct 5, 2026	$ARTV	Sell (Open-market sale)	61.70K	$6.84	$421.83K			-5.0%			Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Aslan Fred traded

• $ARTV

Frequently asked questions

Has Aslan Fred been buying or selling stock?

Aslan Fred has 0 open-market purchases and 2 open-market sales on file, net -$590.71K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Aslan Fred's latest insider trade?

disposed of 23.46K shares of $ARTV on Oct 6, 2026 at $7.20.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.